LYRA
Lyra Therapeutics (LYRA)
$19
About Lyra Therapeutics (LYRA)
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.
Details
Daily high
$0.20
Daily low
$0.19
Price at open
$0.19
52 Week High
$6.79
52 Week Low
$0.16
Market cap
12.6M
Dividend yield
0.00%
Volume
564,029
Avg. volume
1.8M
P/E ratio
-.13
Lyra Therapeutics News
Details
Daily high
$0.20
Daily low
$0.19
Price at open
$0.19
52 Week High
$6.79
52 Week Low
$0.16
Market cap
12.6M
Dividend yield
0.00%
Volume
564,029
Avg. volume
1.8M
P/E ratio
-.13